ALMS (Alumis) Scaled Net Operating Assets : 0.07 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alumis Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Alumis's operating assets for the quarter that ended in Sep. 2024 was $50.69 Mil. Alumis's operating liabilities for the quarter that ended in Sep. 2024 was $33.07 Mil. Alumis's Total Assets for the quarter that ended in Jun. 2024 was $265.18 Mil. Therefore, Alumis's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.07.

Alumis Scaled Net Operating Assets Historical Data

The historical data trend for Alumis's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alumis Scaled Net Operating Assets Chart

Alumis Annual Data

Trend

Dec22

Dec23

Scaled Net Operating Assets

-2.65

-3.29

Alumis Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial			-	-	-5.44	-3.48	0.07

Competitive Comparison of Alumis's Scaled Net Operating Assets

For the Biotechnology subindustry, Alumis's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alumis's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alumis's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Alumis's Scaled Net Operating Assets falls into.

Alumis Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Alumis's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(40.66	-	396.292)	/	108.168
=	-3.29

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	89.612	-	48.952
=	40.66

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	428.872	-	30.86	-	1.72
=	396.292

Alumis's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(50.689	-	33.073)	/	265.179
=	0.07

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	412.559	-	361.87
=	50.689

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	64.171	-	29.631	-	1.467
=	33.073

Alumis Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Alumis's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Alumis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

280 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.alumis.com

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.